I kliniska studier som genomfördes i hepatit C- populationen behandlades patienterna med IntronA enbart eller i kombination med ribavirin i ett år. ###>In clinical trials conducted in the hepatitis C population, patients were treated with IntronA alone or in combination with ribavirin for one year.